What is the new price target for UnitedHealth?

The price target for UnitedHealth was raised from $550 to $600.

Were there any other analyst rating changes?

The report focused only on Broadcom and UnitedHealth, with no other stocks mentioned.

Wall Street: Broadcom Downgraded, UnitedHealth Upgraded

Broadcom (AVGO) and UnitedHealth (UNH) saw analyst rating changes on Wall Street, with Broadcom downgraded and UnitedHealth upgraded.

June 4, 2026

2 min read

Source: The Fly

According to a report from The Fly, shares of Broadcom (AVGO) and UnitedHealth (UNH) have experienced changes in analyst ratings on Wall Street, with Broadcom downgraded and UnitedHealth upgraded.

Rating Changes

Broadcom (AVGO): Downgraded from "Buy" to "Neutral," with a price target cut from $200 to $180.
UnitedHealth (UNH): Upgraded from "Neutral" to "Buy," with a price target increase from $550 to $600.

Analyst Rationale

Broadcom: The analyst believes the current valuation leaves limited upside, especially given slowing growth in the semiconductor sector.
UnitedHealth: Strong fundamentals in healthcare, along with steady revenue growth, support the upgrade.

Context

These changes come amid volatility in the tech sector, while healthcare shows relative resilience. Neither Broadcom nor UnitedHealth has commented.

What to Make of It

These rating changes reflect a divergence in analyst views across sectors, with a current preference for healthcare over technology. Investors should consider these recommendations within their broader investment strategies.

Frequently Asked Questions

Broadcom was downgraded due to high valuation and slowing growth in the semiconductor sector.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.